Research Directory


Click on a region to see local research initiatives.


Birmingham

University of Birmingham

Dr Guy Pratt, Dr Paul Moss, Dr Supratik Basu

T cell immunity, developing T cell immunotherapy and understanding the microenvironment in MM


Nottingham

Nottingham City Hospital

Dr Cathy Williams

Dr Williams’s interests include transplant and novel therapeutic approaches in the treatment of myeloma through the development of, and role as, Chief and Co-investigator in a number of Phase I, II and III clinical trials. She is a member of the NCRI Myeloma Clinical Trials committee and is also involved with Myeloma UK as a scientific advisor, writes for their journal and has spoken at patient seminars.

 


London

Institute of Cancer Research and Royal Marsden Hospital, London

Professor Gareth Morgan

Genetic events involved in switch recombination, clinical trials and prognostic factors

http://www.icr.ac.uk/research/team_leaders/Morgan_Gareth/index.shtml

Click here to see a profile of Professor Morgan


Sheffield

John Snowden

http://www.sheffield.ac.uk/oncology/staffprofiles/js


Sheffield

Sam Ahmedzai

http://www.shef.ac.uk/oncology/staffprofiles/ahmedzai


Sheffield

Dr Andy Chantry

Bone anabolic agents in myeloma

mellanbycentre.dept.shef.ac.uk/members/chantry.htm


Leeds

Dr Roger Owen

Minimal residual in myeloma by flow cytometry

Please click here for a profile of Dr Roger Owen


Leeds

Professor Gordon Cook

Director of Blood and Marrow Transplantation, Leeds

Consultant Haematologist & Honorary Senior Lecturer, University of Leeds

Stem cell transplantation in myeloma, NCRI MMX, MRC MMXI

Professor Gordon Cook is currently the Secretary of the UK Myeloma Forum. Click here to see his profile.


London

Barts and The London NHS Trust

Professor Jamie Cavenagh

Stem cell transplantation in myeloma, AML/MDS; Anti-angiogenic therapies in myeloma. NK cell activity during thalidomide therapy.

Past Chair of the UK Myeloma Forum

Click here for a profile of Professor Cavenagh


London

King’s College Medical School, London

Professor Steve Schey

He has been Chief Investigator and Co-investigator for a large number of clinical trials. His research interests are in multiple myeloma and the bone marrow microenvironment as potential novel therapeutic targets, and haemopoietic stem cell transplantation and he leads the Kings College Myeloma Translational Research Group at the Rayne Institute Denmark Hill


London

Institute of Cancer Research and Royal Marsden Hospital, London

Dr Faith Davies

Targeted approaches to myeloma therapy. Current Chair of the NCRI Myeloma Clinical Trials Committee and Chair of the UKMF.

http://www.ukmf.org.uk/members/FaithDavies.htm

For a profile of Dr Faith Davis, please click here


London

University College, London

Dr Kwee Yong

Myeloma biology and the mechanisms of bone disease.

http://www.uclh.org/OurServices/Consultants/Pages/DrKweeYoung.aspx

For a profile of Dr Kwee Yong, click here


Plymouth

Lyn MaCallum

investigation of CCN2 ‘osteogenic signalling’ in Multiple Myeloma

http://www.plymouth.ac.uk/staff/lmmccallum


Wessex

Wessex Regional Cytogenetics Unit

Fiona Ross

Cytogenetics in myeloma


Newcastle

Professor Graham Jackson

Drug resistance in myeloma, development of long-term bone marrow transplant follow-up clinics, and the cytokine profile of acute and chronic GVHD

http://www.newcastle-hospitals.org.uk/staff-profiles/12195.aspx


No information has been found for this